Opthea Limited
OPTNASDAQHealthcare
$3.41
+$0.05(+1.49%)
Market Cap$4.2B
P/E Ratio—
52W High$6.3
52W Low$1.79
Opthea Limited (OPT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OPT · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2025Report Date: Aug 28, 2025EPS Actual
-$0.20
Est. -$0.05 · -345.5%
Revenue
$0.00B
Est. $0.00B · -98.3%
Fiscal Period
Q3 FY2025
FY ends December
Report Date
Aug 28, 2025
After Market Close
▼ Miss EPS▼ Miss Revenue
OPT reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q1 FY2026 | Feb 26, 2026 | — | — | — | — | $0.00B | — |
| ▼ Q3 FY2025 | Aug 28, 2025 | -$0.05 | -$0.20 | -345.5% | $0.00B | $0.00B | -98.3% |
| ▼ Q1 FY2025 | Feb 26, 2025 | -$0.43 | -$1.65 | -283.1% | $0.00B | $0.00B | -46.1% |
| ▼ Q4 FY2024 | Oct 30, 2024 | -$0.54 | -$1.23 | -127.8% | $0.00B | $0.00B | -21.7% |
| — Q2 FY2024 | Apr 11, 2024 | — | -$0.82 | — | $0.00B | $0.00B | -14.5% |
| ▲ Q3 FY2023 | Sep 12, 2023 | -$1.28 | -$0.64 | +49.9% | $0.00B | $0.00B | -7.9% |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.78 | — | $0.00B | $0.00B | -14.2% |
| — Q3 FY2022 | Aug 29, 2022 | — | -$1.81 | — | $0.00B | — | — |
Q1 FY2026
Feb 26, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 28, 2025Miss
EPS Actual
-$0.20
EPS Est.
-$0.05
EPS Surpr.
-345.5%
Revenue
$0.00B
Q1 FY2025
Feb 26, 2025Miss
EPS Actual
-$1.65
EPS Est.
-$0.43
EPS Surpr.
-283.1%
Revenue
$0.00B
Q4 FY2024
Oct 30, 2024Miss
EPS Actual
-$1.23
EPS Est.
-$0.54
EPS Surpr.
-127.8%
Revenue
$0.00B
Q2 FY2024
Apr 11, 2024
EPS Actual
-$0.82
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2023
Sep 12, 2023Beat
EPS Actual
-$0.64
EPS Est.
-$1.28
EPS Surpr.
+49.9%
Revenue
$0.00B
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.78
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2022
Aug 29, 2022
EPS Actual
-$1.81
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Q1 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $-0.43 | $-0.43 | $-0.43 | 1 |
| Q3 FY2024 | $2.27 | $2.27 | $2.27 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-0.0B | $-0.0B | $-0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q3 FY2025 | Aug 28, 2025 | -345.5% | $3.41 | — | — |
| ▼ Q1 FY2025 | Feb 26, 2025 | -283.1% | $4.71 | $4.62 | -1.91% |
| ▼ Q4 FY2024 | Oct 30, 2024 | -127.8% | $4.58 | $4.36 | -4.80% |
| — Q2 FY2024 | Apr 11, 2024 | — | $3.91 | $3.90 | -0.26% |
| ▲ Q3 FY2023 | Sep 12, 2023 | +49.9% | $2.28 | $2.27 | -0.39% |
| — Q4 FY2022 | Dec 31, 2022 | — | $5.36 | $4.63 | -13.62% |
| — Q3 FY2022 | Aug 29, 2022 | — | $6.27 | $6.39 | +1.91% |
| ▼ Q4 FY2021 | Dec 31, 2021 | -160.6% | $7.65 | $7.55 | -1.31% |
Q3 FY2025—
Report Date
Aug 28, 2025
EPS Beat/Miss
-345.5%
Price Before
$3.41
Price After
—
Q1 FY2025-1.91%
Report Date
Feb 26, 2025
EPS Beat/Miss
-283.1%
Price Before
$4.71
Price After
$4.62
Q4 FY2024-4.80%
Report Date
Oct 30, 2024
EPS Beat/Miss
-127.8%
Price Before
$4.58
Price After
$4.36
Q2 FY2024-0.26%
Report Date
Apr 11, 2024
EPS Beat/Miss
—
Price Before
$3.91
Price After
$3.90
Q3 FY2023-0.39%
Report Date
Sep 12, 2023
EPS Beat/Miss
+49.9%
Price Before
$2.28
Price After
$2.27
Q4 FY2022-13.62%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$5.36
Price After
$4.63
Q3 FY2022+1.91%
Report Date
Aug 29, 2022
EPS Beat/Miss
—
Price Before
$6.27
Price After
$6.39
Q4 FY2021-1.31%
Report Date
Dec 31, 2021
EPS Beat/Miss
-160.6%
Price Before
$7.65
Price After
$7.55
Avg Beat Reaction-0.39%
Avg Miss Reaction-2.67%
Beat Rate1 / 8 quarters
Largest Move-13.62% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OPT ends December
Opthea Limited (OPT) most recently reported earnings on August 28, 2025 for Q3 FY2025, posting EPS of $-0.20 — missing the analyst consensus of $-0.05 by -345.5%. The next OPT earnings date is expected around September 1, 2026.
Each quarter, investors track OPT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OPT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OPT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OPT earnings · 5 questionsOpthea Limited's next earnings report is expected around September 1, 2026. OPT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OPT historically reports after market close (AMC).
OPT earnings datewhen is OPT earningsOPT next earnings datewhen does OPT report earningsOPT earnings calendar
▸ Source: FMP · Opthea Limited SEC filings · US GAAP · Opthea Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026